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PurposeBenzalkonium chloride(benzalkonium chloride, BAK) is one of the most
widely used preservative in ophthalmology. However a large number of basic and
clinical experiments show that long-term use of BAK can cause a series of eye
discomfort .Ocular surface disturbances secondary to the toxic effects of BAK
lead to a shift in inflammatory mediators with further maturation and migration of
Langerhans cells (LCs).Therefore, The main purpose of our study is to investigate
the effect of topical application of benzalkonium chloride on the distribution,
characteristics and expression of cell junction proteins in Langerhans cells.
Methods: Wistar rats were randomly divided into four groups. 0.025%, 0.05%,
0.1% benzalkonium chloride were applied three times one day to both eyes of the
three groups for four weeks, the other group used as the blank control group.
Tear production ,corneal sensitivity , tear break-up time (BUT),and fluorescein
staining were performed on days 0,7, 14,28. After a clinical examination was
carried out, the rats were killed. Whole mount corneas were analyzed by
immunofluorescence double staining for the alternations of MHC-, ZO-1, β-
catenin, CD80 in corneal dendritic cells(DCs). Nerve-specific antibody β-Tubulin
III were used to observe the effect of BAK on the corneal nerves.
Results: Compared with the control group, local application of BAK can cause
tear secretion and corneal sensitivity decreased rapidly, long-term application
decreased significantly. BUT and fluorescein staining did not change significantly
in the three administrations. Immunofluorescence staining and confocal
microscopy showed that MHC-II positive DCs were found in the epithelium and
the stroma in the normal cornea and these cells did not express the complex
stimulating molecules B7-1 (CD80) and cell junction protein ZO-1 and beta-
catenin in the noninflammatory state. After local application of BAK, the epithelial













and began to express the tight junction protein ZO-1 and the adhesion protein β-
catenin. Three-dimensional reconstruction images of epithelial TJs and LCs in the
mouse cornea demonstrated a direct contact of LCs dendrites with the cell
junction proteins. A decrease in the density of the sub-basal nerve fibers and an
increase in the curvature of the nerve fibers were observed.
Conclusions: BAK can induce the maturation and migration of corneal DCs and
express cell junction protein, suggesting that BAK can not only alter the
maturation of corneal DCs but also change the function of antigen up-taking of
corneal DCs.     
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